The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Business continuity ensures that an organization can continue to operate in the event of a serious incident or disaster and encompasses strategic…
Webcast
Brent Petty, executive industry consultant, Healthcare Lexmark International, discusses what forces are currently affecting health care and the pla
Webcast
Allen Archer, System Director of Supply Chain at Houston Healthcare, leads a thought-leader panel discussion about the role of GPOs within the chan
On-Demand Educational Webinars
At Hershey Penn State Medical Center, the supply chain and ED nursing team came together in a Kaizen process to reinvent the way supplies were being…
On-Demand Educational Webinars
This webinar takes a deep look at industries that have evolved successful and meaningful supplier relationships to advance shared value among a…